Protara applies modern science, manufacturing, and regulatory expertise to reimagine proven medicines and deliver new ...

Not all cardiac arrests can be treated with an electric shock. In fact, most of them—about 80%—are ineligible for ...

Eli Lilly is reconsidering plans for its U.K. biotech-focused Gateway Labs, citing concerns about the industry’s outlook in ...

AstraZeneca has paused a 200 million pound sterling ($271 million) investment in its Cambridge, England research site, a ...

Like approved Alzheimer’s meds Kisunla (donanemab) and Leqembi (lecanemab), as well as the discontinued Aduhelm (aducanemab), ...

The Trump administration is considering putting “severe restrictions” on the increasing flow of investigational drugs from ...

Novartis is paying $1.4 billion to get its hands on Tourmaline Bio and its former Pfizer cardiovascular drug that impressed ...

U.S. nonprofit Wellcome Leap is partnering with the Melinda French Gates-founded coalition Pivotal, raising $100 million to ...

Exact Sciences has launched its long-awaited blood test designed to detect the early stages of multiple tumors, with a plan ...

With its head of U.S. business Julie Kim sliding up to the CEO spot next June, Takeda has locked in a replacement in Rhona ...

FibroGen has agreed to pay $1.25 million to the Securities and Exchange Commission (SEC) to address allegations that the ...

Arrowhead Pharmaceuticals has launched legal action against Ionis Pharmaceuticals, aiming to neutralize Ionis' claim that ...